Nigeria aims to produce its own medicines following a recent €10.2 million project called QUALIMED with the European Union and France. The Quality Uplift for Advancing Local Industry in Medicine Standards (QUALIMED) project will help reduce a costly reliance on imports.
Right now, Nigeria imports most of its medicine leading to shortages and high costs. According to reports, the initiative will facilitate new factories and labs. This’ll improve Nigeria’s steady access to affordable, and life-saving drugs.
Additionally, the funds will help upgrade key medical laboratories to world-class standards, and support scientists in vital research. For instance, the funding will modernise the National Institute for Pharmaceutical Research and Development (NIPRD), elevating it to a regional hub for advanced testing and quality control. As a result, young medicine hopefuls will get enough resources to grow and help the Nigerian community.
Moreover, this is also a smart move for the climate future. With climate change disrupting weather and spreading diseases, having a strong local health industry means Nigeria can respond faster to its own needs without depending on western countries.
EU Ambassador Gautier Mignot captured the vision, stating, “Let’s combine the strength of our partnership… [towards] making Nigerian healthcare life-saving and sustainable, diversified, accessible, and affordable for all.” This sentiment was echoed by France’s Ambassador, Marc Fonbaustier, who highlighted “equity, solidarity, and human dignity” as core principles.
The QUALIMED project is more than just aid; it’s an investment in a healthier, more self-reliant future for Nigeria and a model for all of West Africa.
Add a Comment